Journal of Clinical Medicine (Aug 2022)

A Comparison of the Catheter-Based Transapical and Surgical Treatment Modalities for Mitral Paravalvular Leak

  • Aleksejus Zorinas,
  • Vilius Janušauskas,
  • Donatas Austys,
  • Giedrius Davidavičius,
  • Lina Puodžiukaitė,
  • Diana Zakarkaitė,
  • Robertas Stasys Samalavičius,
  • Karolis Urbonas,
  • Rita Kramena,
  • Eustaquio Maria Onorato,
  • Kęstutis Ručinskas

DOI
https://doi.org/10.3390/jcm11174999
Journal volume & issue
Vol. 11, no. 17
p. 4999

Abstract

Read online

Background: There is a lack of studies where the outcomes of mitral paravalvular leak treatment were compared between surgery and catheter-based closure. The aim of this study was to compare the outcomes of re-do surgery with transapical catheter-based paravalvular leak closure. Methods: This is a retrospective observational study at a single institution; 76 patients were included. According to the treatment, two groups were formed: the “Surgical” group (49 patients after re-do surgery) and the “Catheter” group (27 patients after transapical catheter–based treatment). Results: In-hospital myocardial infarction occurred in 9 (18%) cases in the “Surgical” group and none in the “Catheter” group, p = 0.018. Procedure-related life-threatening bleeding occurred in 9 (18%) patients in the “Surgical” group and none in the “Catheter” group, p = 0.018. Nine (18%) patients died in 30 days in the “Surgical” group, and none died in the “Catheter” group, p = 0.039. A mean follow-up was 3.3 years. No difference was found between the groups by the degree of residual paravalvular regurgitation either at discharge or at follow-up. During the follow-up, 19 (39%) patients died in the “Surgical” group and 2 (7%) among the “Catheter” patients. Conclusions: Transapical catheter-based closure of mitral paravalvular leak seems to be a safer treatment procedure than conventional re-do surgery, and the effectiveness of these procedures does not differ.

Keywords